Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Finerenone
Related studies linked through entity extraction aliases.
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
- Status
- RECRUITING
- Phase
- PHASE3
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4